1. Introduction
Radiation injury, caused by exposure to ionizing radiation (including X-rays, gamma rays, and particle radiation), can lead to significant damage to body tissues and organs. Common manifestations include skin ulcers, vascular stenosis, nerve injury, and impaired wound healing. Hyperbaric oxygen therapy (HBOT) with a hyperbaric chamber is a widely recognized adjuvant treatment approach for radiation injury. By delivering 100% oxygen at pressures above atmospheric pressure, hyperbaric chambers help increase oxygen delivery to hypoxic tissues, support angiogenesis, and regulate inflammatory responses, which in turn aid tissue repair and optimize clinical results.
2. Mechanisms of Hyperbaric Oxygen in Treating Radiation Injury
2.1 Enhancing Tissue Oxygenation
Ionizing radiation can damage microvasculature, resulting in reduced blood flow and tissue hypoxia-key factors contributing to delayed wound healing and progressive tissue necrosis in radiation injury. In a hyperbaric environment, the partial pressure of oxygen in blood plasma rises substantially (even without hemoglobin), allowing oxygen to diffuse more deeply into hypoxic tissues. This increased oxygenation helps restore the metabolic activity of viable cells, suppress the proliferation of anaerobic bacteria (which often complicate radiation-induced wounds), and establish a foundation for tissue repair.
2.2 Promoting Angiogenesis and Tissue Regeneration
Radiation-induced damage to endothelial cells can hinder the body's ability to form new blood vessels (angiogenesis). Hyperbaric oxygen helps stimulate the production of vascular endothelial growth factor (VEGF) and other pro-angiogenic factors, which promote the proliferation and migration of endothelial cells, thereby supporting the regeneration of damaged microvasculature. Additionally, HBOT enhances the activity of fibroblasts, which play a crucial role in collagen synthesis and granulation tissue formation-important processes for wound healing.
2.3 Modulating Inflammatory Responses
Radiation injury can trigger a persistent inflammatory response that may worsen tissue damage. Hyperbaric oxygen helps regulate the function of inflammatory cells (such as neutrophils and macrophages), reducing the release of pro-inflammatory cytokines and reactive oxygen species (ROS). This anti-inflammatory effect helps alleviate tissue edema and oxidative stress, creating a favorable microenvironment for tissue repair.
2.4 Reducing Fibrosis
Chronic radiation injury is often associated with excessive collagen deposition and tissue fibrosis, which can lead to organ dysfunction (e.g., radiation-induced lung fibrosis, intestinal stricture). HBOT helps inhibit the activation of myofibroblasts (the primary cells responsible for collagen synthesis) and promotes the degradation of excess collagen, which may reduce fibrosis and improve tissue flexibility and function.
3. Indications for Hyperbaric Chamber Treatment in Radiation Injury
Hyperbaric chamber therapy is commonly considered for the following types of radiation-induced injuries, based on clinical guidelines and practice:
Radiation-induced skin injury: Including acute radiation dermatitis (severe erythema, blisters, ulcers) and chronic radiation skin damage (non-healing ulcers, skin necrosis, fibrosis).
Radiation-induced osteoradionecrosis (ORN): Necrosis of bone and surrounding soft tissues caused by radiation, most commonly affecting the jaw (following head and neck radiation therapy) and pelvic bones.
Radiation cystitis and proctitis: Inflammatory and ulcerative lesions of the bladder or rectum resulting from pelvic radiation, characterized by hematuria, dysuria, or rectal bleeding.
Delayed radiation-induced wound healing: Wounds (e.g., surgical incisions, traumatic wounds) in previously irradiated areas that fail to heal with conventional treatment.
Radiation-induced neuropathy: Nerve damage caused by radiation, leading to pain, numbness, or motor dysfunction, where tissue hypoxia contributes to symptom persistence.
4. Hyperbaric Chamber Treatment Protocol for Radiation Injury
4.1 Pre-Treatment Evaluation
Before undergoing HBOT, a comprehensive evaluation is necessary to confirm the diagnosis of radiation injury, assess the extent of tissue damage, and exclude contraindications (e.g., untreated pneumothorax, severe chronic obstructive pulmonary disease, unmanageable claustrophobia). Evaluations may include physical examination, imaging studies (ultrasound, CT, MRI), blood tests, and wound cultures (if infection is suspected).
4.2 Treatment Parameters
Common HBOT protocols for radiation injury generally include the following parameters, which may be adjusted based on individual patient conditions:
Pressure: 2.0–2.5 atmospheres absolute (ATA). Higher pressures may be used for severe cases (e.g., advanced osteoradionecrosis) under close monitoring.
Oxygen concentration: 100% medical oxygen.
Treatment duration: 90–120 minutes per session (including pressure elevation, oxygen breathing, and pressure reduction phases).
Treatment frequency: 5–7 sessions per week, with a total course of 20–40 sessions. The course length may be adjusted based on the severity of injury and wound healing progress.
4.3 Intra-Treatment Monitoring
During each HBOT session, continuous monitoring of patients' vital signs (heart rate, blood pressure, oxygen saturation) is performed. Additionally, signs of oxygen toxicity (e.g., convulsions, visual disturbances) or barotrauma (e.g., ear pain, sinus pressure, lung injury) are closely observed. Nurses or hyperbaric medicine specialists are on-site to promptly address any adverse events that may occur.
4.4 Post-Treatment Follow-Up
After completing a course of HBOT, patients receive regular follow-up evaluations to assess wound healing progress, tissue function recovery, and symptom recurrence. For persistent or progressive injuries, additional courses of HBOT may be considered. Concomitant treatments (e.g., wound care, antibiotics for infection, pain management) are often continued alongside HBOT to optimize treatment results.
5. Contraindications and Adverse Effects
5.1 Contraindications
HBOT is not recommended for patients with the following conditions, as it may pose potential risks:
Untreated pneumothorax (risk of lung rupture under increased pressure).
Severe chronic obstructive pulmonary disease (COPD) with hypercapnia (inability to eliminate excess carbon dioxide, which can be exacerbated by oxygen therapy).
Certain congenital heart defects (e.g., cyanotic heart disease with right-to-left shunts, where oxygenated blood is shunted away from tissues).
Malignant tumors (theoretical risk of promoting tumor growth, though this is controversial and HBOT may be used cautiously in some cases of radiation-induced injury with no active tumor).
Uncontrolled seizures or claustrophobia that cannot be managed with medication.
5.2 Adverse Effects
Most adverse effects of HBOT are mild and reversible. Common ones include:
Barotrauma: Ear pain, sinus pain, or middle ear injury due to pressure changes. This can be minimized by having patients perform pressure-equalizing maneuvers (e.g., swallowing, yawning) during pressure elevation.
Oxygen toxicity: Rare at standard treatment pressures, but may manifest as central nervous system symptoms (convulsions, headache, nausea) or pulmonary symptoms (chest pain, cough) with prolonged or high-pressure exposure.
Temporary myopia: Caused by changes in the lens of the eye due to oxygen exposure, usually resolving within weeks after treatment cessation.
Fatigue: Common after prolonged sessions, typically alleviated with rest.
6. Clinical Evidence and Outcomes
A large number of clinical studies have explored the application of HBOT in radiation injury treatment. For instance, in patients with radiation-induced osteoradionecrosis of the jaw, research has shown that HBOT may improve wound healing rates, reduce pain, and reduce the need for invasive surgical interventions (e.g., bone resection) in some cases. Similarly, for radiation-induced skin ulcers, HBOT may accelerate granulation tissue formation and wound closure compared to conventional wound care alone.
Meta-analyses of randomized controlled trials (RCTs) have indicated that HBOT may significantly improve healing outcomes in chronic radiation-induced wounds and reduce the risk of disease progression in osteoradionecrosis. However, the optimal timing of HBOT (early vs. delayed after radiation exposure) and specific treatment parameters are still subjects of ongoing research. Individual patient responses may vary depending on the extent of injury, comorbidities, and treatment adherence.
7. Future Directions
Future research on hyperbaric chamber therapy for radiation injury focuses on the following aspects:
Refine treatment protocols (pressure, duration, frequency) based on injury type and severity to maximize efficacy and minimize adverse effects.
Explore the combination of HBOT with other regenerative therapies (e.g., stem cell therapy, growth factor administration) to enhance tissue repair.
Develop biomarkers to predict patient response to HBOT, enabling personalized treatment plans.
Investigate the use of HBOT in preventing radiation injury (e.g., pre-radiation HBOT to protect normal tissues) and treating acute radiation syndrome (ARS) in cases of high-dose radiation exposure.
8. Conclusion
Hyperbaric chamber therapy is a valuable adjuvant treatment option for radiation injury. It exerts effects through enhancing tissue oxygenation, promoting angiogenesis, and regulating inflammation, thereby aiding tissue repair and improving clinical outcomes. It should be noted that HBOT is not a universal solution and needs to be used in combination with appropriate wound care and supportive therapies. Clinical practice has shown that HBOT may bring significant benefits to patients with various radiation-induced injuries, from skin ulcers to osteoradionecrosis. With continuous research on optimizing treatment protocols and personalized care, hyperbaric oxygen therapy is expected to play an increasingly important role in the management of radiation injury.